Actavis Inc has recalled BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, in 30-count bottles. The recall is necessary because the tablets failed to meet approved dissolution specifications at the 8-hour test point. This means the medication may not release or absorb as intended. No remedy details are currently provided in this record. Read more at govinfonow.com/recall/46736-actavis-inc-recalls-bupropion-hydrochloride-extended-release-tablets-xl-300.
“Actavis Recalls BuPROPion Hydrochloride XL 300mg Tablets.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46736-actavis-inc-recalls-bupropion-hydrochloride-extended-release-tablets-xl-300. Based on FDA recall #D-855-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-855-2013%22&limit=1).
The FDA announced on July 31, 2013, that Actavis Inc voluntarily recalled BuPROPion Hydrochloride Extended-Release Tablets (XL) due to failed dissolution specifications. The agency issued recall number D-855-2013 for the Class III drug.
The recall addresses BuPROPion Hydrochloride Extended-Release Tablets (XL) where dissolution test results at the 8-hour time-point exceeded approved specification limits. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Actavis Inc has 13 other recalls on record since March 22, 2013. Other recent recalls of similar products include Teva Metoprolol Succinate Extended-Release Tablets Recall (Jan. 29, 2026), Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026), and Inventia Chlorthalidone Recall (Sept. 3, 2026).
How to tell if you have this one
Check your bottle for NDC 67767-142-30 and UPC 3 67767-142-30 6. Verify the lot number is CG2D18A with an expiration date of 06/14. The product is BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, in 30-count bottles.
Brand
Actavis
Product
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Verify if your bottle matches NDC 67767-142-30, UPC 3 67767-142-30 6, Lot CG2D18A, and Exp 06/14.
Consult Your Pharmacist
Contact your pharmacist or healthcare provider to discuss the recall and determine next steps for your prescription.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-855-2013 (July 31, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-855-2013 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.